These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6004861)

  • 1. Discussion on the pharmacology of the fenamates.
    Ann Phys Med; 1966; Suppl():70-6. PubMed ID: 6004861
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antiproteolytic properties of nonsteroid anti-inflammatory agents].
    Trinus FP; Veremeenko KN; Mokhort NA; Kizim AI
    Farmakol Toksikol; 1969; 32(6):715-8. PubMed ID: 5309715
    [No Abstract]   [Full Text] [Related]  

  • 3. Discussion on clinical trials of the fenamates.
    Ann Phys Med; 1966; Suppl():129-34. PubMed ID: 5306340
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental observations on flufenamic, mefenamic and meclofenamic acids. 3. Metabolic disposition.
    Glazko AJ
    Ann Phys Med; 1966; Suppl():23-36. PubMed ID: 4979052
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative anti-inflammatory, analgesic, antopyretic and toxic effect of mefenamic acid, butadion and sodium salicylate].
    Trinus FP; Mokhort NA
    Farmakol Toksikol; 1971; 34(3):306-11. PubMed ID: 5568689
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacological properties of a series of derivatives of mefenamic and flufenamic acids].
    Linari G; Spanò R
    Farmaco Sci; 1971 Apr; 26(4):303-11. PubMed ID: 5559990
    [No Abstract]   [Full Text] [Related]  

  • 7. [Anti-inflammatory action of N-(2,6-dichlorophenyl)-o-aminophenylacetic acid, its sodium salt, N-(2,6-dichlorophenyl)-anthranilic acid and its sodium salt. 1. On acute inflammation].
    Tsurumi K; Hiramatsu Y; Nozaki M; Hayashi M; Shibuya T
    Nihon Yakurigaku Zasshi; 1973 Mar; 69(2):299-318. PubMed ID: 4807882
    [No Abstract]   [Full Text] [Related]  

  • 8. [Contribution to the evaluation of anti-inflammatory agents in vitro].
    Mörsdorf K; Cornelissen G
    Med Pharmacol Exp Int J Exp Med; 1966; 15(4):399-403. PubMed ID: 6012770
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anti-inflammatory action of N-(2,6-dichlorophenyl)-o-aminophenylacetic acid, its sodium salt, N-(2,6-dichlorophenyl)-anthranilic acid and its sodium salt. 2. On subacute inflammation].
    Tsurumi K; Hiramatsu Y; Yamaguchi A; Hayashi M; Shibuya T
    Nihon Yakurigaku Zasshi; 1973 Mar; 69(2):319-34. PubMed ID: 4807883
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of non-steroid anti-inflammatory agents on proliferative processes in the inflammation focus].
    Mokhort NA
    Farmakol Toksikol; 1971; 34(3):297-300. PubMed ID: 5568687
    [No Abstract]   [Full Text] [Related]  

  • 11. [Relationship between the inhibition of ATPase activity and inflammatory edema by nonsteroid anti-inflammatory drugs. Approach to the screening test in vitro of nonsteroid anti-inflammatory drugs].
    Aizawa Y; Iwasaki M
    Nihon Yakurigaku Zasshi; 1970 Jul; 66(4):394-9. PubMed ID: 4250435
    [No Abstract]   [Full Text] [Related]  

  • 12. [Absorption and effect of N-(alpha, alpha, alpha-trifluoro-m-tolyl)-anthranilic acid after cutaneous application].
    Panse P; Zeiller P; Sensch KH
    Arzneimittelforschung; 1971 Oct; 21(10):1605-8. PubMed ID: 5171894
    [No Abstract]   [Full Text] [Related]  

  • 13. New therapy in bronchial asthma. An evaluation of ponstel (mefenamic acid) in chronic bronchial asthma and pulmonary emphysema.
    Jackson RH; Raymer WJ; Etter RL
    J Kans Med Soc; 1968 Oct; 69(10):474-8. PubMed ID: 5705538
    [No Abstract]   [Full Text] [Related]  

  • 14. Glucuronidation of fenamates: kinetic studies using human kidney cortical microsomes and recombinant UDP-glucuronosyltransferase (UGT) 1A9 and 2B7.
    Gaganis P; Miners JO; Knights KM
    Biochem Pharmacol; 2007 May; 73(10):1683-91. PubMed ID: 17343829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Statistical evaluation of the therapeutic effect of a new antirheumatic drug, mefenamic acid, on rheumatoid arthritis].
    Colombo B; Mantellini P; Caruso I
    Reumatismo; 1967; 19(5):317-27. PubMed ID: 5617956
    [No Abstract]   [Full Text] [Related]  

  • 16. Mefenamic acid.
    Br Med J; 1966 Dec; 2(5528):1506-7. PubMed ID: 5333309
    [No Abstract]   [Full Text] [Related]  

  • 17. Experimental observations on flufenamic, mefanamic and meclofenamic acids. II. Toxicology in animals.
    Kaump DH
    Ann Phys Med; 1966; Suppl():16-23. PubMed ID: 4979051
    [No Abstract]   [Full Text] [Related]  

  • 18. [Double-blind study using flufenamic acid (F.I. 440) and oxyphenylbutazone in rheumatoid arthritis and ankylosing spine].
    Beltrán Gutiérrez J; Fernández del Vallado P; Gijón Baños J
    Rev Esp Reum Enferm Osteoartic; 1968 Oct; 12(8):219-21. PubMed ID: 4899416
    [No Abstract]   [Full Text] [Related]  

  • 19. [Synthesis and pharmacologic property of anthranilic acid-N-(aryl-substitutes)].
    Picciola G; Gaggi R; Caliari W
    Farmaco Sci; 1968 May; 23(5):502-11. PubMed ID: 5680389
    [No Abstract]   [Full Text] [Related]  

  • 20. Tolfenamic acid. Detection and structure of urinary metabolites.
    Pedersen SB; Alhede B; Buchardt O; Møller J; Bock K
    Arzneimittelforschung; 1981; 31(11):1944-8. PubMed ID: 7198475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.